Behenoyl cytarabine-associated reversible encephalopathy in a patient with acute myelogenous leukemia.

We report a case of reversible encephalopathy syndrome in a 16-year-old girl with acute myelogenous leukemia (AML), who is undergoing during consolidation chemotherapy composed of BH-AC (N4-behenoyl-1-beta-D-arabinofuranosyl cytosine) and idarubicin. On the 6th day of chemotherapy, she was in a drow...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, S. G., Moon, H., Lee, J. H., Lee, S. Y., Kim, C. C., Lee, K. S.
Formato: Texto
Lenguaje:English
Publicado: Korean Academy of Medical Sciences 1999
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054166/
https://www.ncbi.nlm.nih.gov/pubmed/10102531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3054166/
https://www.ncbi.nlm.nih.gov/pubmed/10102531

Ejemplares similares